Evia Bio™ is a life science innovation company enabling the growing cell therapy market. We provide new non-DMSO cryopreservation solutions developed by world-leading cryobiologist, Allison Hubel, PhD. We partner with cell therapy companies looking to advance their products to clinical trials and commercialization. Our solutions unlock the full potential of emerging life-saving therapies through the use of all-natural organic compounds to protect the integrity of cells during cryopreservation and patient safety at the point of care.
Please visit www.eviabio.com.
Company Details
- Employees
- 11
- Address
- 2001 6th St Se,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://eviabio.com/
- HQ
- Minneapolis, Minnesota
Evia Bio Questions
Evia Bio's website is https://eviabio.com/
Evia Bio's LinkedIn profile is https://www.linkedin.com/company/evia-bio
Evia Bio has
11 employees.
View email and phone details for 11
employees at Evia Bio.
Evia Bio's industry is
Biotechnology Research
Evia Bio's top competitors are
Cellipont Bioservices,
Immatics,
Cellready™,
Bullpen,
Verdot,
Biohouston,
Ctmc,
Marker Therapeutics, Inc.,
Vgxi,
Parhelia Biosciences.
Evia Bio's categories are Biotechnology Research
